Stipulated Dismissal Undercuts Bid for Attorneys Fees
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by: Jeremy Anapol
UNITED CANNABIS CORPORATION V. PURE HEMP COLLECTIVE INC.
Before Lourie, Cunningham, and Stark. Appeal from the United States District Court for the District of Colorado.
Summary: The Federal Circuit affirmed the district court’s refusal to award attorneys’ fees based on alleged inequitable conduct where the party seeking fees had stipulated to the dismissal of its inequitable-conduct counterclaim.
UCANN filed suit against Pure Hemp for patent infringement and the parties later stipulated to the dismissal of UCANN’s patent infringement claims and Pure Hemp’s counterclaim for inequitable conduct. Pure Hemp then moved for attorney’s fees on various grounds, including that UCANN’s prosecution counsel had allegedly committed inequitable conduct. The district court denied the fee motion.
The Federal Circuit found that because Pure Hemp voluntarily dismissed its counterclaim for inequitable conduct, the district court was not obligated to make any findings on the merits of that counterclaim. Further, the limited record from the district court revealed that there was a genuine dispute as to whether any inequitable conduct occurred because UCANN’s attorney stated that she believed in good faith she did not need to disclose the prior art to the PTO. Thus, the Federal Circuit affirmed the district court’s denial of attorneys’ fees.
Editor: Paul Stewart
Jamal Perry New York Bar Admission Pending
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…